Your browser doesn't support javascript.
loading
Trends of HbA1c and BMI in People with Type 2 Diabetes: A Japanese Claims-Based Study.
Hara, Kazuo; Hirase, Tetsuaki; Pathadka, Swathi; Cai, Zhihong; Sato, Manaka; Ishida, Noriyuki; Takemura, Ryo.
Afiliação
  • Hara K; Department of Medicine, Jichi Medical University Saitama Medical Center, Saitama, Japan.
  • Hirase T; Japan Drug Development and Medical Affairs, Eli Lilly Japan K.K., Kobe, Japan.
  • Pathadka S; Lilly Capability Center India, Eli Lilly Services India Private Limited, Primrose 7B, Embassy Tech Village, Devarabisanahalli, Bengaluru, Karnataka, 560103, India. pathadka_swathi@lilly.com.
  • Cai Z; Japan Drug Development and Medical Affairs, Eli Lilly Japan K.K., Kobe, Japan.
  • Sato M; Japan Drug Development and Medical Affairs, Eli Lilly Japan K.K., Kobe, Japan.
  • Ishida N; Biostatistics Unit, Clinical and Translational Research Center, Keio University Hospital, Tokyo, Japan.
  • Takemura R; Biostatistics Unit, Clinical and Translational Research Center, Keio University Hospital, Tokyo, Japan.
Diabetes Ther ; 15(4): 801-817, 2024 Apr.
Article em En | MEDLINE | ID: mdl-38401022
ABSTRACT

INTRODUCTION:

Obesity prevalence has increased in Japan in recent years. Given the strong association of obesity with poor glycemic control, and increased risk of type 2 diabetes (T2D) with central obesity, this study describes the current trends and relationships between glycated hemoglobin (HbA1c), body mass index (BMI), and waist circumference in the Japanese people with T2D.

METHODS:

This was a retrospective, cross-sectional study of people with T2D who had at least one recorded HbA1c and BMI (or waist circumference) value in the Japan Medical Data Center Claims database. Five annual cohorts of the study population were formed between January 2017 and December 2021. Annual trends of HbA1c across BMI categories (obesity class I [≥ 25 ~ < 30 kg/m2]-IV [≥ 40 kg/m2]) and in people with central obesity (waist circumference ≥ 85 cm in men; ≥ 90 cm in women) were described by sex and age groups.

RESULTS:

Overall, 106,089 people with T2D (HbA1c and BMI data 106,079; HbA1c and waist circumference data 105,424) were included, with the majority of people belonging to obesity class I (range 39.7-40.6%) and obesity class II (range 16.2-17.7%) categories across all annual cohorts. People in higher BMI categories had higher mean HbA1c, with > 50% of people with T2D in obesity class I-IV (54.8-56.5%) having HbA1c ≥ 7%. Between 2017 and 2021, BMI and waist circumference increased in the age group 18-44 years. More than 50% of people with T2D and central obesity in both sexes and people of age group 18-44 years across obesity class I-IV or with central obesity had HbA1c ≥ 7%.

CONCLUSION:

More than half of the people with T2D belonging to obesity class I-IV or central obesity had poor glycemic control (HbA1c ≥ 7%), especially in the 18-44 age group. This highlights the need for body weight management for better glycemic control in relatively young Japanese people with T2D and obesity.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article